Continuity Biosciences - Crunchbase Company Profile & Funding

Q: How much funding has Continuity Biosciences raised to date?

Continuity Biosciences has raised obfuscated.

Overview

Continuity Biosciences

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Continuity Biosciences

CB Rank

18001

Continuity Biosciences is a bio-technology company.

Founded

obfuscation

Private

Venture - Series Unknown

Bradenton, Florida, United States

1-10

continuitybiosciences.com

Biotechnology

Business Intelligence

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Krishna Venugopalan: Co-founder and Chief Executive Officer
Alessandro Grattoni: Chief Scientific Officer

Details

Legal Name

Continuity Biosciences, LLC

Operating Status

Active

Company Type

For Profit

Founders

Alessandro Grattoni, Krishna Venugopalan, Robert Whitehead

About the Company

Continuity Biosciences is a biotech business. The business is focused on developing and commercializing innovative drug delivery technologies, with a special emphasis on cell reprogramming, immune regulation, and ultra-long-acting delivery systems.

Phone Number

1 919-480-3892

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

Neovascularized Implantable Cell Homing and Encapsulation (NICHE) platform

A 3D-printed implant that creates a vascularized environment to support long-term cell engraftment and local immune modulation.

NanoLymph platform

A 3D-printed device with dual reservoirs for in vivo cell recruitment, reprogramming, and immunomodulatory agent release.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Continuity Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Continuity Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Continuity Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Continuity Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Continuity Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Continuity Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Continuity Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Continuity Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Continuity Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Continuity Biosciences	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Investments

Investment Breakdown

Number of Investments

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Pinprint	Yes	Corporate Round - Pinprint	obfuscated obfuscation
obfuscated obfuscation	Pinprint	Yes	Corporate Round - Pinprint	obfuscated obfuscation
obfuscated obfuscation	Pinprint	Yes	Corporate Round - Pinprint	obfuscated obfuscation
obfuscated obfuscation	Pinprint	Yes	Corporate Round - Pinprint	obfuscated obfuscation
obfuscated obfuscation	Pinprint	Yes	Corporate Round - Pinprint	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Pinprint	Yes	Corporate Round - Pinprint	obfuscated obfuscation
obfuscated obfuscation	Pinprint	Yes	Corporate Round - Pinprint	obfuscated obfuscation
obfuscated obfuscation	Pinprint	Yes	Corporate Round - Pinprint	obfuscated obfuscation
obfuscated obfuscation	Pinprint	Yes	Corporate Round - Pinprint	obfuscated obfuscation
obfuscated obfuscation	Pinprint	Yes	Corporate Round - Pinprint	obfuscated obfuscation